Verbatim response from ChatGPT
Short answer
- If you want the largest average weight loss seen in recent trials and have no contraindications, ask your clinician about Zepbound (tirzepatide).
- If you prefer a drug with a longer track record specifically marketed for obesity and sometimes broader insurance coverage, ask about Wegovy (semaglutide). Either requires a prescription and a clinician to evaluate you.
Key differences (brief)
- Drug class/mechanism: Wegovy = semaglutide (GLP‑1). Zepbound = tirzepatide (GIP + GLP‑1 dual agonist).
- Effect on weight: Clinical trials show tirzepatide (Zepbound) produces larger average weight loss than semaglutide (Wegovy).
- Side effects/risks: Both cause GI side effects (nausea, diarrhea, vomiting, constipation) and share boxed warnings about thyroid C‑cell tumors (avoid with personal/family history of medullary thyroid carcinoma or MEN2). Both need clinical monitoring.
- Track record/coverage: Wegovy has been on the market longer for obesity; coverage and familiarity among clinicians may be better in some plans.
Who should consider each
- Consider Zepbound if maximizing weight loss is your priority and you have no contraindications and can tolerate the medication.
- Consider Wegovy if you want a well-established obesity drug with somewhat broader prescriber experience and possibly better insurance coverage depending on your plan.
- If you have type 2 diabetes, discuss both options with your prescriber — tirzepatide also lowers blood glucose strongly.
Where to get them online (reputable paths)
- Start with your primary care doctor, endocrinologist or a board-certified obesity medicine specialist — they can evaluate you and e‑prescribe to any pharmacy (CVS, Walgreens, Walmart, Kroger, etc.).
- Telehealth clinics that commonly evaluate and prescribe GLP‑1 / obesity meds: Ro (getro.co), Hims & Hers (himshers.com), One Medical (onemedical.com), and Profile by Sanford (profileplan.com). These companies provide virtual visits and can send prescriptions to your chosen pharmacy. (Availability and formulary vary by state.)
- Manufacturer resources/savings: Novo Nordisk (Wegovy) and Eli Lilly (Zepbound) have patient support programs and savings or copay assistance—check the official brand websites for enrollment and eligibility.
- Your insurance’s mail‑order pharmacy or specialty pharmacy can also fill these prescriptions once prescribed.
Safety, monitoring and practical tips
- You must be evaluated (medical history, pregnancy status if relevant, thyroid cancer family history, etc.) and monitored for side effects, blood glucose, and possibly labs.
- Ask your clinician about dose escalation schedules (start low, increase gradually) and what to do for intolerable GI symptoms.
- Beware of unregulated “doctors” or online sellers that ship without a proper medical evaluation or offer compounded or foreign-brand GLP‑1s — use reputable telemedicine services or local prescribers and licensed pharmacies.
- Check insurance coverage before you assume cost: these drugs are expensive without coverage. Manufacturer savings programs and patient assistance may help.
What to say to your clinician (copy/paste) “I’m interested in prescription treatment for obesity. Can we discuss Wegovy (semaglutide) versus Zepbound (tirzepatide)? I’d like to know which is likely best for me given my medical history, likely benefits, side effects, dosing plan, monitoring, and insurance coverage.”
If you want, tell me:
- any medical history (diabetes, thyroid disease, pancreatitis, pregnancy plans) and insurance status and I’ll help you refine which is most appropriate and which telehealth options might accept you.